William Galle - Unilife Corp Independent Non-Executive Director
Director
Mr. William Galle is no longer an Independent NonExecutive Director of Unilife Corporationration effective December 15 2016. Mr. Galle was affiliated as an investment banker with Bradley Woods a 40 yearold New York Citybased independent research and investment banking firm specializing in federal regulatory and legislative developments impacting substantial investor portfolios. Since 1993 Mr. Galle was president of Diversified Portfolio Strategies LLC in Washington D.C. which provides alternative investment advisory services for institutions and substantial investors. Mr. Galle was also an independent director of American Marketing Complex in New York City from October 2007 to December 2009. Prior to his time at Diversified Portfolio Strategies LLC Mr. Galle was vice president of pension services at Smith Barney Harris Upham and director of corporate services at NASDAQ in Washington D.C. Mr. Galle is a graduate of Columbia University Rutgers University and the New York Institute of Finance. since 2009.
| Age | 75 |
| Tenure | 15 years |
| Phone | 717 384-3400 |
| Web | www.unilife.com |
Unilife Corp Management Efficiency
The company has return on total asset (ROA) of (0.48) % which means that it has lost $0.48 on every $100 spent on assets. This is way below average. Unilife Corp's management efficiency ratios could be used to measure how well Unilife Corp manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 105.11 M in liabilities. Unilife Corp has a current ratio of 0.55, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Unilife Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Unilife Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Unilife Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Unilife to invest in growth at high rates of return. When we think about Unilife Corp's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Thomas Gunderson | Merit Medical Systems | 66 | |
| Joseph Galante | Cumberland Pharmaceuticals | 68 | |
| Stuart Randle | Teleflex Incorporated | 61 | |
| Thomas Lawrence | Cumberland Pharmaceuticals | 74 | |
| Ann Millner | Merit Medical Systems | 65 | |
| Patricia Barron | Teleflex Incorporated | 73 | |
| Elizabeth Huebner | Merit Medical Systems | 60 | |
| WILLIAM Cook | Teleflex Incorporated | 71 | |
| Richard Packer | Teleflex Incorporated | 62 | |
| Joey Jacobs | Cumberland Pharmaceuticals | 63 | |
| John Heinmiller | Teleflex Incorporated | 66 | |
| David Liu | Merit Medical Systems | 43 | |
| Martin Cearnal | Cumberland Pharmaceuticals | 69 | |
| Scott Anderson | Merit Medical Systems | 70 | |
| George Babich | Teleflex Incorporated | 69 | |
| Jill Anderson | Merit Medical Systems | 58 | |
| James Jones | Cumberland Pharmaceuticals | 67 | |
| Franklin Miller | Merit Medical Systems | 76 | |
| Kim Foster | Teleflex Incorporated | 68 | |
| Kent Stanger | Merit Medical Systems | 62 | |
| Jeffrey Graves | Teleflex Incorporated | 55 | |
Management Performance
| Return On Asset | -0.48 |
Unilife Corp Leadership Team
Elected by the shareholders, the Unilife Corp's board of directors comprises two types of representatives: Unilife Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Unilife. The board's role is to monitor Unilife Corp's management team and ensure that shareholders' interests are well served. Unilife Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Unilife Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Duane DeSisto, Director | ||
| Mary Wold, Independent Non-Executive Director | ||
| Molly Weaver, Chief Compliance Officer, Vice President - Quality and Regulatory Affairs | ||
| Kevin Sellers, Senior Vice President - Marketing and Communications | ||
| Alan Shortall, Chairman, CEO and Member of Strategic Partnerships Committee | ||
| David Hastings, CFO | ||
| Ian Hanson, Senior Vice President General Manager - Wearable Injector and Auto Injector | ||
| Mark Iampietro, Vice President - Quality and Regulatory Affairs | ||
| Dennis Pyers, Interim CFO, Chief Accounting Officer, Vice President Controller | ||
| Jeff Carter, Non-Executive Director, Investor Relations Support | ||
| Richard Beckman, Senior Vice President and Chief Medical Officer | ||
| Michael Kamarck, Director | ||
| Ramin Mojdehbakhsh, President COO | ||
| John Ryan, Senior Vice President General Counsel, Secretary | ||
| William Galle, Independent Non-Executive Director | ||
| John Lund, Independent Non-Executive Director | ||
| Michael Ratigan, Senior Vice President and Chief Commercial Officer | ||
| Harry Hamill, Director | ||
| Stephanie Walters, Senior Vice President General Counsel, Secretary | ||
| Rosemary Crane, Director |
Unilife Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Unilife Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.48 | |||
| Profit Margin | (6.79) % | |||
| Operating Margin | (502.04) % | |||
| Current Valuation | 129.57 M | |||
| Shares Outstanding | 16.67 M | |||
| Shares Owned By Insiders | 11.06 % | |||
| Shares Owned By Institutions | 37.90 % | |||
| Number Of Shares Shorted | 2.02 M | |||
| Price To Earning | (0.03) X | |||
| Price To Book | 37.85 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Unilife Corp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Unilife Corp's short interest history, or implied volatility extrapolated from Unilife Corp options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Unilife Stock
If you are still planning to invest in Unilife Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Unilife Corp's history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |